HEADER IMMUNE SYSTEM 31-JUL-10 2XN9 TITLE CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL TITLE 2 RECEPTOR, STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR TITLE 3 HISTOCOMPATIBILITY COMPLEX CLASS II COMPND MOL_ID: 1; COMPND 2 MOLECULE: T CELL RECEPTOR ALPHA CHAIN C REGION; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 1-95; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: VARIABLE DOMAIN TRAV27 FUSED TO CONSTANT DOMAIN; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: T CELL RECEPTOR BETA-1 CHAIN C REGION; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 1-130; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES; COMPND 14 OTHER_DETAILS: VARIABLE DOMAIN TRBV19 FUSED TO CONSTANT DOMAIN; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: ENTEROTOXIN H; COMPND 17 CHAIN: C; COMPND 18 SYNONYM: SEH, STAPHYLOCOCCAL ENTEROTOXIN H; COMPND 19 ENGINEERED: YES; COMPND 20 MOL_ID: 4; COMPND 21 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN,; COMPND 22 CHAIN: D; COMPND 23 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 26-207; COMPND 24 SYNONYM: MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II ALPHA, MHC CLASS COMPND 25 II ANTIGEN DRA CHAIN; COMPND 26 ENGINEERED: YES; COMPND 27 OTHER_DETAILS: CHAIN DR 0101; COMPND 28 MOL_ID: 5; COMPND 29 MOLECULE: MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II BETA CHAIN; COMPND 30 CHAIN: E; COMPND 31 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 30-219; COMPND 32 SYNONYM: MHC CLASS II ANTIGEN DRB1.1, DR-1, DR1; COMPND 33 ENGINEERED: YES; COMPND 34 OTHER_DETAILS: CHAIN DRB1 0101; COMPND 35 MOL_ID: 6; COMPND 36 MOLECULE: HEMAGGLUTININ; COMPND 37 CHAIN: F; COMPND 38 FRAGMENT: RESIDUES 59-71; COMPND 39 SYNONYM: INFLUENZA HEMAGGLUTININ PEPTIDE; COMPND 40 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: T LYMPHOCYTE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGMT7; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 CELL: T LYMPHOCYTE; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PGMT7; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 21 ORGANISM_TAXID: 1280; SOURCE 22 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 83333; SOURCE 24 EXPRESSION_SYSTEM_STRAIN: K-12; SOURCE 25 EXPRESSION_SYSTEM_VARIANT: UL635; SOURCE 26 MOL_ID: 4; SOURCE 27 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 28 ORGANISM_COMMON: HUMAN; SOURCE 29 ORGANISM_TAXID: 9606; SOURCE 30 CELL: ANTIGEN PRESENTING CELL; SOURCE 31 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 32 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 33 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYS; SOURCE 34 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 35 MOL_ID: 5; SOURCE 36 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 37 ORGANISM_COMMON: HUMAN; SOURCE 38 ORGANISM_TAXID: 9606; SOURCE 39 CELL: ANTIGEN PRESENTING CELL; SOURCE 40 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 41 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 42 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 43 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 44 MOL_ID: 6; SOURCE 45 SYNTHETIC: YES; SOURCE 46 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 47 ORGANISM_TAXID: 11320 KEYWDS IMMUNE SYSTEM, SUPERANTIGEN, IMMUNORECEPTORS, TERNARY COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.SALINE,K.E.J.RODSTROM,G.FISCHER,V.Y.OREKHOV,B.G.KARLSSON, AUTHOR 2 K.LINDKVIST-PETERSSON REVDAT 4 16-OCT-24 2XN9 1 REMARK REVDAT 3 20-DEC-23 2XN9 1 REMARK LINK REVDAT 2 03-AUG-11 2XN9 1 JRNL REMARK HETSYN VERSN REVDAT 1 24-NOV-10 2XN9 0 JRNL AUTH M.SALINE,K.E.J.RODSTROM,G.FISCHER,V.Y.OREKHOV,B.G.KARLSSON, JRNL AUTH 2 K.LINDKVIST-PETERSSON JRNL TITL THE STRUCTURE OF SUPERANTIGEN COMPLEXED WITH TCR AND MHC JRNL TITL 2 REVEALS NOVEL INSIGHTS INTO SUPERANTIGENIC T CELL JRNL TITL 3 ACTIVATION. JRNL REF NAT.COMMUN. V. 1 119 2010 JRNL REFN ESSN 2041-1723 JRNL PMID 21081917 JRNL DOI 10.1038/NCOMMS1117 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 152.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 58700 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3148 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3577 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 211 REMARK 3 BIN FREE R VALUE : 0.3580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8266 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.75000 REMARK 3 B22 (A**2) : 2.02000 REMARK 3 B33 (A**2) : -0.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.62000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.316 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.248 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.181 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.350 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8646 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11751 ; 1.443 ; 1.947 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1059 ; 6.671 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 439 ;36.530 ;24.579 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1435 ;18.278 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 51 ;19.710 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1259 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6722 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5250 ; 0.794 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8514 ; 1.488 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3396 ; 1.875 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3237 ; 3.061 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2XN9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-JUL-10. REMARK 100 THE DEPOSITION ID IS D_1290043900. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : TOROIDAL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61858 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 42.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OGA CHAINS D, E AND PDB ENTRY 1HXY REMARK 200 CHAINS A, B, D REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% W/V PEG 5000 MME, 0.1 M BIS-TRIS REMARK 280 PH 7.0, 0.1 M NACL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 95.59000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.44500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 95.59000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.44500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -94.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, THR 49 TO CYS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, SER 57 TO CYS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 201 REMARK 465 GLU A 202 REMARK 465 SER A 203 REMARK 465 SER A 204 REMARK 465 MET B 1 REMARK 465 VAL B 2 REMARK 465 LYS C 216 REMARK 465 VAL C 217 REMARK 465 ILE D 1 REMARK 465 LYS D 2 REMARK 465 GLU D 3 REMARK 465 ALA D 182 REMARK 465 GLY E 1 REMARK 465 ALA E 190 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 2 CG CD OE1 NE2 REMARK 470 LEU A 3 CG CD1 CD2 REMARK 470 GLN A 95 CG CD OE1 NE2 REMARK 470 GLN A 113 CG CD OE1 NE2 REMARK 470 ASP A 129 CG OD1 OD2 REMARK 470 GLU B 17 CG CD OE1 OE2 REMARK 470 SER B 189 OG REMARK 470 SER B 218 OG REMARK 470 GLU B 219 CG CD OE1 OE2 REMARK 470 LYS C 131 CG CD CE NZ REMARK 470 LYS C 214 CG CD CE NZ REMARK 470 LYS D 38 CG CD CE NZ REMARK 470 LEU D 99 CG CD1 CD2 REMARK 470 GLU D 172 CG CD OE1 OE2 REMARK 470 LYS E 98 CG CD CE NZ REMARK 470 LEU E 109 CG CD1 CD2 REMARK 470 GLN E 110 CG CD OE1 NE2 REMARK 470 HIS E 111 CG ND1 CD2 CE1 NE2 REMARK 470 GLU E 128 CG CD OE1 OE2 REMARK 470 ARG E 133 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 139 CG CD CE NZ REMARK 470 VAL E 164 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 157 CA - CB - CG ANGL. DEV. = 16.5 DEGREES REMARK 500 ARG B 193 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 59 -116.06 54.25 REMARK 500 ALA A 92 -64.75 -98.37 REMARK 500 GLN A 95 -68.29 -105.27 REMARK 500 ASN A 97 160.34 82.78 REMARK 500 SER A 127 -9.06 -49.24 REMARK 500 ASP A 129 30.37 -93.55 REMARK 500 ASP A 166 52.55 38.65 REMARK 500 ASN B 55 -7.43 84.27 REMARK 500 PHE B 76 69.95 -150.09 REMARK 500 ALA B 182 20.24 -78.86 REMARK 500 ASP B 185 44.18 -104.61 REMARK 500 ASN B 220 -32.24 -166.28 REMARK 500 GLN B 225 170.35 -58.60 REMARK 500 ASP B 226 -78.32 -36.32 REMARK 500 GLU C 38 -24.88 55.09 REMARK 500 ASN C 45 16.88 55.40 REMARK 500 ASN C 70 97.87 -69.43 REMARK 500 SER C 86 -164.24 -129.49 REMARK 500 LEU C 93 134.90 -172.77 REMARK 500 SER C 205 -72.11 -81.06 REMARK 500 ASP D 27 12.44 52.12 REMARK 500 PRO D 96 129.91 -33.09 REMARK 500 ASN D 124 -67.82 69.03 REMARK 500 HIS D 143 15.61 85.86 REMARK 500 GLU D 158 13.19 -68.19 REMARK 500 PRO D 173 129.50 -35.39 REMARK 500 THR E 3 -21.77 99.51 REMARK 500 ASN E 19 76.60 66.99 REMARK 500 ASN E 33 60.56 35.65 REMARK 500 GLN E 34 -7.06 69.53 REMARK 500 THR E 90 -68.56 -129.61 REMARK 500 THR E 106 -128.93 -155.04 REMARK 500 GLN E 107 137.85 89.09 REMARK 500 LEU E 109 66.59 -155.39 REMARK 500 GLN E 110 153.56 72.70 REMARK 500 ASP E 152 17.88 7.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA C1216 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2030 O REMARK 620 2 HIS C 23 O 109.6 REMARK 620 3 SER C 77 O 92.6 155.7 REMARK 620 4 SER C 77 OG 155.1 91.2 70.1 REMARK 620 5 HOH C2011 O 99.6 82.2 84.6 96.6 REMARK 620 6 HOH C2028 O 87.0 92.1 98.9 78.4 172.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA C 1216 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1246 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1247 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB REMARK 900 RELATED ID: 1ENF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H DETERMINED TO REMARK 900 1.69 A RESOLUTION REMARK 900 RELATED ID: 2ESV RELATED DB: PDB REMARK 900 STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX REMARK 900 RELATED ID: 1SEB RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 ANDTHE REMARK 900 BACTERIAL SUPERANTIGEN SEB REMARK 900 RELATED ID: 1JWS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS IIMOLECULE HLA- REMARK 900 DR1 (HA PEPTIDE 306-318) WITH THESUPERANTIGEN SEC3 VARIANT 3B1 REMARK 900 RELATED ID: 1H15 RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/ DRB5*0101 COMPLEXED WITH REMARK 900 A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE. REMARK 900 RELATED ID: 1F77 RELATED DB: PDB REMARK 900 STAPHYLOCOCCAL ENTEROTOXIN H DETERMINED TO 2. 4 A RESOLUTION REMARK 900 RELATED ID: 2SEB RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM REMARK 900 HUMAN COLLAGEN II REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 2WBJ RELATED DB: PDB REMARK 900 TCR COMPLEX REMARK 900 RELATED ID: 1KLU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED REMARK 900 WITHSTAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2) REMARK 900 RELATED ID: 1FYT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELLRECEPTOR, REMARK 900 INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS IIMOLECULE, HLA-DR1 REMARK 900 RELATED ID: 1PYW RELATED DB: PDB REMARK 900 HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNEDPEPTIDE REMARK 900 RELATED TO INFLUENZA VIRUS HEMAGGLUTININ, FVKQNA(MAA)AL, IN COMPLEX REMARK 900 WITH STAPHYLOCOCCAL ENTEROTOXINC3 VARIANT 3B2 (SEC3-3B2) REMARK 900 RELATED ID: 1J8H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELLRECEPTOR, REMARK 900 INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS IIMOLECULE, HLA-DR4 REMARK 900 RELATED ID: 1KLG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37, THR28-->ILE MUTANT) REMARK 900 COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2(SEC3 -3B2) REMARK 900 RELATED ID: 2G9H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) INCOMPLEX REMARK 900 WITH A HUMAN MHC CLASS II MOLECULE REMARK 900 RELATED ID: 1KTK RELATED DB: PDB REMARK 900 COMPLEX OF STREPTOCOCCAL PYROGENIC ENTEROTOXIN C (SPEC)WITH A HUMAN REMARK 900 T CELL RECEPTOR BETA CHAIN (VBETA2.1) REMARK 900 RELATED ID: 1DLH RELATED DB: PDB REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1D5Z RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC REMARK 900 RELATED ID: 2EYR RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR SELECTION AND CROSS- SPECIESREACTIVITY OF REMARK 900 THE SEMI-INVARIANT NKT CELL RECEPTOR INCD1D/GLYCOLIPID RECOGNITION REMARK 900 RELATED ID: 1T5X RELATED DB: PDB REMARK 900 HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE(AAYSDQATPLLLSPR) AND REMARK 900 THE SUPERANTIGEN SEC3-3B2 REMARK 900 RELATED ID: 1A6A RELATED DB: PDB REMARK 900 THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP REMARK 900 BOUND TO HLA-DR3 REMARK 900 RELATED ID: 1KG0 RELATED DB: PDB REMARK 900 STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TOTHE MHC REMARK 900 CLASS II RECEPTOR HLA-DR1 REMARK 900 RELATED ID: 1BX2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101, DRB1*1501) COMPLEXEDWITH A REMARK 900 PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN REMARK 900 RELATED ID: 1D5M RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE REMARK 900 RELATED ID: 1LO5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCALENTEROTOXIN REMARK 900 A IN COMPLEX WITH HUMAN MHC CLASS II REMARK 900 RELATED ID: 1HXY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H INCOMPLEX WITH REMARK 900 HUMAN MHC CLASS II REMARK 900 RELATED ID: 1HQR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH- AFFINITY, REMARK 900 ZINC-DEPENDENT SITE ON MHC CLASS II REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1KGC RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 2CDG RELATED DB: PDB REMARK 900 STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA- REMARK 900 GALACTOSYLCERAMIDE- SPECIFIC T CELL RECEPTORS (TCR 5B) REMARK 900 RELATED ID: 1FV1 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANTPEPTIDE FROM REMARK 900 MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BYTWO HLA-DR2 ALLELES REMARK 900 RELATED ID: 1SJH RELATED DB: PDB REMARK 900 HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE REMARK 900 RELATED ID: 2EYS RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR SELECTION AND CROSS- SPECIESREACTIVITY OF REMARK 900 THE SEMI-INVARIANT NKT CELL RECEPTOR INCD1D/GLYCOLIPID RECOGNITION REMARK 900 RELATED ID: 2BNU RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1JWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS IIMOLECULE HLA- REMARK 900 DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGENSEC3 REMARK 900 RELATED ID: 2CDF RELATED DB: PDB REMARK 900 STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA- REMARK 900 GALACTOSYLCERAMIDE- SPECIFIC T CELL RECEPTORS (TCR 5E) REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8- EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 1YMM RELATED DB: PDB REMARK 900 TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX REMARK 900 RELATED ID: 1R5I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX REMARK 900 RELATED ID: 1ZGL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP /HLA-DR2A REMARK 900 RELATED ID: 1EWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ZN2+ LOADED STAPHYLOCOCCAL ENTEROTOXIN H REMARK 900 RELATED ID: 1T5W RELATED DB: PDB REMARK 900 HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE(AAYSDQATPLLLSPR) REMARK 900 RELATED ID: 1D5X RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC REMARK 900 RELATED ID: 2AXH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATEDTO REMARK 900 RHEUMATOID ARTHRITIS REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 2EYT RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR SELECTION AND CROSS- SPECIESREACTIVITY OF REMARK 900 THE SEMI-INVARIANT NKT CELL RECEPTOR INCD1D/GLYCOLIPID RECOGNITION REMARK 900 RELATED ID: 1SJE RELATED DB: PDB REMARK 900 HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDEBOUND IN A REMARK 900 HAIRPIN CONFORMATION REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 1JWU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS IIMOLECULE HLA- REMARK 900 DR1 (HA PEPTIDE 306-318) WITH THESUPERANTIGEN SEC3 VARIANT 3B2 REMARK 900 RELATED ID: 2CDE RELATED DB: PDB REMARK 900 STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA- REMARK 900 GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR REMARK 900 RELATED ID: 2XNA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL REMARK 900 RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN H REMARK 999 REMARK 999 SEQUENCE REMARK 999 CHAIN A RESIDUES 1-109 CONTAINS THE TCR VARIABLE DOMAIN TRAV27. REMARK 999 ALPHA CHAIN RESIDUES 96-142 ARE EXCLUDED. REMARK 999 CHAIN B RESIDUES 1-114 CONTAINS THE TCR VARIABLE DOMAIN TRBV19. REMARK 999 BETA CHAIN RESIDUES 131-177 ARE EXCLUDED. REMARK 999 SIGNAL SEQUENCES (RESIDUES B1-24, C1-25, D1-29) NOT IN CONSTRUCTS. REMARK 999 SYNTHETIC PEPTIDE F OF 13 RESIDUES, 306-318 OF INFLUENZA REMARK 999 HEMAGGLUTININ. DBREF 2XN9 A 1 109 PDB 2XN9 2XN9 1 109 DBREF 2XN9 A 110 204 UNP P01848 TCA_HUMAN 1 95 DBREF 2XN9 B 1 114 PDB 2XN9 2XN9 1 114 DBREF 2XN9 B 115 244 UNP P01850 TRBC1_HUMAN 1 130 DBREF 2XN9 C 1 217 UNP P0A0M0 ETXH_STAAU 25 241 DBREF 2XN9 D 1 182 UNP P01903 DRA_HUMAN 26 207 DBREF 2XN9 E 1 190 UNP P04229 2B11_HUMAN 30 219 DBREF 2XN9 F 1 13 UNP A8CDU0 A8CDU0_9INFA 59 71 SEQADV 2XN9 CYS A 158 UNP P01848 THR 49 ENGINEERED MUTATION SEQADV 2XN9 LYS B 118 UNP P01850 ASN 4 CONFLICT SEQADV 2XN9 ASN B 119 UNP P01850 LYS 5 CONFLICT SEQADV 2XN9 TYR B 151 UNP P01850 PHE 37 CONFLICT SEQADV 2XN9 CYS B 171 UNP P01850 SER 57 ENGINEERED MUTATION SEQADV 2XN9 SER B 189 UNP P01850 CYS 75 CONFLICT SEQRES 1 A 204 MET GLN LEU LEU GLU GLN SER PRO GLN PHE LEU SER ILE SEQRES 2 A 204 GLN GLU GLY GLU ASN LEU THR VAL TYR CYS ASN SER SER SEQRES 3 A 204 SER VAL PHE SER SER LEU GLN TRP TYR ARG GLN GLU PRO SEQRES 4 A 204 GLY GLU GLY PRO VAL LEU LEU VAL THR VAL VAL THR GLY SEQRES 5 A 204 GLY GLU VAL LYS LYS LEU LYS ARG LEU THR PHE GLN PHE SEQRES 6 A 204 GLY ASP ALA ARG LYS ASP SER SER LEU HIS ILE THR ALA SEQRES 7 A 204 ALA GLN PRO GLY ASP THR GLY LEU TYR LEU CYS ALA GLY SEQRES 8 A 204 ALA GLY SER GLN GLY ASN LEU ILE PHE GLY LYS GLY THR SEQRES 9 A 204 LYS LEU SER VAL LYS PRO ASN ILE GLN ASN PRO ASP PRO SEQRES 10 A 204 ALA VAL TYR GLN LEU ARG ASP SER LYS SER SER ASP LYS SEQRES 11 A 204 SER VAL CYS LEU PHE THR ASP PHE ASP SER GLN THR ASN SEQRES 12 A 204 VAL SER GLN SER LYS ASP SER ASP VAL TYR ILE THR ASP SEQRES 13 A 204 LYS CYS VAL LEU ASP MET ARG SER MET ASP PHE LYS SER SEQRES 14 A 204 ASN SER ALA VAL ALA TRP SER ASN LYS SER ASP PHE ALA SEQRES 15 A 204 CYS ALA ASN ALA PHE ASN ASN SER ILE ILE PRO GLU ASP SEQRES 16 A 204 THR PHE PHE PRO SER PRO GLU SER SER SEQRES 1 B 244 MET VAL ASP GLY GLY ILE THR GLN SER PRO LYS TYR LEU SEQRES 2 B 244 PHE ARG LYS GLU GLY GLN ASN VAL THR LEU SER CYS GLU SEQRES 3 B 244 GLN ASN LEU ASN HIS ASP ALA MET TYR TRP TYR ARG GLN SEQRES 4 B 244 ASP PRO GLY GLN GLY LEU ARG LEU ILE TYR TYR SER GLN SEQRES 5 B 244 ILE VAL ASN ASP PHE GLN LYS GLY ASP ILE ALA GLU GLY SEQRES 6 B 244 TYR SER VAL SER ARG GLU LYS LYS GLU SER PHE PRO LEU SEQRES 7 B 244 THR VAL THR SER ALA GLN LYS ASN PRO THR ALA PHE TYR SEQRES 8 B 244 LEU CYS ALA SER SER SER ARG SER SER TYR GLU GLN TYR SEQRES 9 B 244 PHE GLY PRO GLY THR ARG LEU THR VAL THR GLU ASP LEU SEQRES 10 B 244 LYS ASN VAL PHE PRO PRO GLU VAL ALA VAL PHE GLU PRO SEQRES 11 B 244 SER GLU ALA GLU ILE SER HIS THR GLN LYS ALA THR LEU SEQRES 12 B 244 VAL CYS LEU ALA THR GLY PHE TYR PRO ASP HIS VAL GLU SEQRES 13 B 244 LEU SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY SEQRES 14 B 244 VAL CYS THR ASP PRO GLN PRO LEU LYS GLU GLN PRO ALA SEQRES 15 B 244 LEU ASN ASP SER ARG TYR SER LEU SER SER ARG LEU ARG SEQRES 16 B 244 VAL SER ALA THR PHE TRP GLN ASN PRO ARG ASN HIS PHE SEQRES 17 B 244 ARG CYS GLN VAL GLN PHE TYR GLY LEU SER GLU ASN ASP SEQRES 18 B 244 GLU TRP THR GLN ASP ARG ALA LYS PRO VAL THR GLN ILE SEQRES 19 B 244 VAL SER ALA GLU ALA TRP GLY ARG ALA ASP SEQRES 1 C 217 GLU ASP LEU HIS ASP LYS SER GLU LEU THR ASP LEU ALA SEQRES 2 C 217 LEU ALA ASN ALA TYR GLY GLN TYR ASN HIS PRO PHE ILE SEQRES 3 C 217 LYS GLU ASN ILE LYS SER ASP GLU ILE SER GLY GLU LYS SEQRES 4 C 217 ASP LEU ILE PHE ARG ASN GLN GLY ASP SER GLY ASN ASP SEQRES 5 C 217 LEU ARG VAL LYS PHE ALA THR ALA ASP LEU ALA GLN LYS SEQRES 6 C 217 PHE LYS ASN LYS ASN VAL ASP ILE TYR GLY ALA SER PHE SEQRES 7 C 217 TYR TYR LYS CYS GLU LYS ILE SER GLU ASN ILE SER GLU SEQRES 8 C 217 CYS LEU TYR GLY GLY THR THR LEU ASN SER GLU LYS LEU SEQRES 9 C 217 ALA GLN GLU ARG VAL ILE GLY ALA ASN VAL TRP VAL ASP SEQRES 10 C 217 GLY ILE GLN LYS GLU THR GLU LEU ILE ARG THR ASN LYS SEQRES 11 C 217 LYS ASN VAL THR LEU GLN GLU LEU ASP ILE LYS ILE ARG SEQRES 12 C 217 LYS ILE LEU SER ASP LYS TYR LYS ILE TYR TYR LYS ASP SEQRES 13 C 217 SER GLU ILE SER LYS GLY LEU ILE GLU PHE ASP MET LYS SEQRES 14 C 217 THR PRO ARG ASP TYR SER PHE ASP ILE TYR ASP LEU LYS SEQRES 15 C 217 GLY GLU ASN ASP TYR GLU ILE ASP LYS ILE TYR GLU ASP SEQRES 16 C 217 ASN LYS THR LEU LYS SER ASP ASP ILE SER HIS ILE ASP SEQRES 17 C 217 VAL ASN LEU TYR THR LYS LYS LYS VAL SEQRES 1 D 182 ILE LYS GLU GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR SEQRES 2 D 182 LEU ASN PRO ASP GLN SER GLY GLU PHE MET PHE ASP PHE SEQRES 3 D 182 ASP GLY ASP GLU ILE PHE HIS VAL ASP MET ALA LYS LYS SEQRES 4 D 182 GLU THR VAL TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SEQRES 5 D 182 SER PHE GLU ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL SEQRES 6 D 182 ASP LYS ALA ASN LEU GLU ILE MET THR LYS ARG SER ASN SEQRES 7 D 182 TYR THR PRO ILE THR ASN VAL PRO PRO GLU VAL THR VAL SEQRES 8 D 182 LEU THR ASN SER PRO VAL GLU LEU ARG GLU PRO ASN VAL SEQRES 9 D 182 LEU ILE CYS PHE ILE ASP LYS PHE THR PRO PRO VAL VAL SEQRES 10 D 182 ASN VAL THR TRP LEU ARG ASN GLY LYS PRO VAL THR THR SEQRES 11 D 182 GLY VAL SER GLU THR VAL PHE LEU PRO ARG GLU ASP HIS SEQRES 12 D 182 LEU PHE ARG LYS PHE HIS TYR LEU PRO PHE LEU PRO SER SEQRES 13 D 182 THR GLU ASP VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY SEQRES 14 D 182 LEU ASP GLU PRO LEU LEU LYS HIS TRP GLU PHE ASP ALA SEQRES 1 E 190 GLY ASP THR ARG PRO ARG PHE LEU TRP GLN LEU LYS PHE SEQRES 2 E 190 GLU CYS HIS PHE PHE ASN GLY THR GLU ARG VAL ARG LEU SEQRES 3 E 190 LEU GLU ARG CYS ILE TYR ASN GLN GLU GLU SER VAL ARG SEQRES 4 E 190 PHE ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU SEQRES 5 E 190 LEU GLY ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS SEQRES 6 E 190 ASP LEU LEU GLU GLN ARG ARG ALA ALA VAL ASP THR TYR SEQRES 7 E 190 CYS ARG HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL SEQRES 8 E 190 GLN ARG ARG VAL GLU PRO LYS VAL THR VAL TYR PRO SER SEQRES 9 E 190 LYS THR GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SEQRES 10 E 190 SER VAL SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG SEQRES 11 E 190 TRP PHE ARG ASN GLY GLN GLU GLU LYS ALA GLY VAL VAL SEQRES 12 E 190 SER THR GLY LEU ILE GLN ASN GLY ASP TRP THR PHE GLN SEQRES 13 E 190 THR LEU VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU SEQRES 14 E 190 VAL TYR THR CYS GLN VAL GLU HIS PRO SER VAL THR SER SEQRES 15 E 190 PRO LEU THR VAL GLU TRP ARG ALA SEQRES 1 F 13 PRO LYS TYR VAL LYS GLN ASN THR LEU LYS LEU ALA THR HET GOL A1201 6 HET GOL B1245 6 HET GOL B1246 6 HET GOL B1247 6 HET NA C1216 1 HETNAM GOL GLYCEROL HETNAM NA SODIUM ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 7 GOL 4(C3 H8 O3) FORMUL 11 NA NA 1+ FORMUL 12 HOH *280(H2 O) HELIX 1 1 GLN A 80 THR A 84 5 5 HELIX 2 2 ARG A 163 ASP A 166 5 4 HELIX 3 3 ALA A 182 PHE A 187 1 6 HELIX 4 4 ASP B 116 VAL B 120 5 5 HELIX 5 5 SER B 131 GLN B 139 1 9 HELIX 6 6 ALA B 198 GLN B 202 1 5 HELIX 7 7 ASP C 5 LEU C 9 5 5 HELIX 8 8 THR C 10 HIS C 23 1 14 HELIX 9 9 GLY C 47 ASN C 51 5 5 HELIX 10 10 THR C 59 LYS C 67 1 9 HELIX 11 11 LEU C 135 LYS C 151 1 17 HELIX 12 12 ASN C 185 ASP C 190 1 6 HELIX 13 13 LYS C 191 GLU C 194 5 4 HELIX 14 14 GLU D 47 ALA D 52 1 6 HELIX 15 15 GLU D 55 SER D 77 1 23 HELIX 16 16 THR E 51 LEU E 53 5 3 HELIX 17 17 GLY E 54 SER E 63 1 10 HELIX 18 18 GLN E 64 ALA E 73 1 10 HELIX 19 19 ALA E 73 TYR E 78 1 6 HELIX 20 20 TYR E 78 GLY E 86 1 9 HELIX 21 21 GLU E 87 GLN E 92 1 6 SHEET 1 AA 5 GLU A 5 SER A 7 0 SHEET 2 AA 5 LEU A 19 ASN A 24 -1 O TYR A 22 N SER A 7 SHEET 3 AA 5 ASP A 71 ILE A 76 -1 O SER A 72 N CYS A 23 SHEET 4 AA 5 LEU A 61 PHE A 65 -1 O THR A 62 N HIS A 75 SHEET 5 AA 5 VAL A 55 LEU A 58 -1 O LYS A 56 N PHE A 63 SHEET 1 AB 4 PHE A 10 GLN A 14 0 SHEET 2 AB 4 THR A 104 LYS A 109 1 O LYS A 105 N LEU A 11 SHEET 3 AB 4 GLY A 85 GLY A 91 -1 O GLY A 85 N LEU A 106 SHEET 4 AB 4 ILE A 99 PHE A 100 1 O ILE A 99 N GLY A 91 SHEET 1 AC 5 PHE A 10 GLN A 14 0 SHEET 2 AC 5 THR A 104 LYS A 109 1 O LYS A 105 N LEU A 11 SHEET 3 AC 5 GLY A 85 GLY A 91 -1 O GLY A 85 N LEU A 106 SHEET 4 AC 5 LEU A 32 GLN A 37 -1 O GLN A 33 N ALA A 90 SHEET 5 AC 5 VAL A 44 VAL A 49 -1 O VAL A 44 N ARG A 36 SHEET 1 AD 2 ILE A 99 PHE A 100 0 SHEET 2 AD 2 GLY A 85 GLY A 91 1 O GLY A 91 N ILE A 99 SHEET 1 AE 2 VAL A 152 ILE A 154 0 SHEET 2 AE 2 PHE A 167 SER A 176 -1 O TRP A 175 N TYR A 153 SHEET 1 AF 2 CYS A 158 MET A 162 0 SHEET 2 AF 2 PHE A 167 SER A 176 -1 O PHE A 167 N MET A 162 SHEET 1 BA 2 VAL B 170 THR B 172 0 SHEET 2 BA 2 TYR B 188 SER B 197 -1 O ARG B 193 N CYS B 171 SHEET 1 BB 2 LEU B 177 LYS B 178 0 SHEET 2 BB 2 TYR B 188 SER B 197 1 O SER B 189 N LEU B 177 SHEET 1 BC 4 ILE B 6 SER B 9 0 SHEET 2 BC 4 VAL B 21 GLN B 27 -1 O SER B 24 N SER B 9 SHEET 3 BC 4 LEU B 78 VAL B 80 -1 O LEU B 78 N LEU B 23 SHEET 4 BC 4 TYR B 66 VAL B 68 -1 O SER B 67 N THR B 79 SHEET 1 BD 4 TYR B 12 LYS B 16 0 SHEET 2 BD 4 THR B 109 THR B 114 1 O ARG B 110 N LEU B 13 SHEET 3 BD 4 ALA B 89 SER B 96 -1 O ALA B 89 N LEU B 111 SHEET 4 BD 4 TYR B 104 PHE B 105 -1 O TYR B 104 N SER B 95 SHEET 1 BE 6 TYR B 12 LYS B 16 0 SHEET 2 BE 6 THR B 109 THR B 114 1 O ARG B 110 N LEU B 13 SHEET 3 BE 6 ALA B 89 SER B 96 -1 O ALA B 89 N LEU B 111 SHEET 4 BE 6 ALA B 33 ASP B 40 -1 O ALA B 33 N SER B 96 SHEET 5 BE 6 GLY B 44 ILE B 53 -1 O GLY B 44 N ASP B 40 SHEET 6 BE 6 ASP B 56 LYS B 59 -1 O ASP B 56 N ILE B 53 SHEET 1 BF 2 TYR B 104 PHE B 105 0 SHEET 2 BF 2 ALA B 89 SER B 96 -1 O SER B 95 N TYR B 104 SHEET 1 BG 4 LYS B 164 VAL B 166 0 SHEET 2 BG 4 VAL B 155 VAL B 161 -1 O TRP B 159 N VAL B 166 SHEET 3 BG 4 HIS B 207 PHE B 214 -1 O ARG B 209 N TRP B 160 SHEET 4 BG 4 GLN B 233 TRP B 240 -1 O GLN B 233 N PHE B 214 SHEET 1 CA 3 PHE C 25 ILE C 30 0 SHEET 2 CA 3 VAL C 71 GLY C 75 -1 O VAL C 71 N ILE C 30 SHEET 3 CA 3 THR C 97 LEU C 99 -1 O THR C 98 N ASP C 72 SHEET 1 CB 5 ILE C 35 SER C 36 0 SHEET 2 CB 5 ASP C 40 PHE C 43 -1 O ASP C 40 N SER C 36 SHEET 3 CB 5 ASP C 52 LYS C 56 -1 O LEU C 53 N PHE C 43 SHEET 4 CB 5 SER C 90 TYR C 94 1 O GLU C 91 N ARG C 54 SHEET 5 CB 5 SER C 77 PHE C 78 -1 O PHE C 78 N CYS C 92 SHEET 1 CC 2 ILE C 119 GLN C 120 0 SHEET 2 CC 2 LYS C 103 VAL C 116 -1 O VAL C 116 N ILE C 119 SHEET 1 CD 2 GLU C 124 LYS C 130 0 SHEET 2 CD 2 LYS C 103 VAL C 116 -1 N LEU C 104 O ASN C 129 SHEET 1 CE 5 TYR C 174 ASP C 177 0 SHEET 2 CE 5 LYS C 161 MET C 168 -1 O ILE C 164 N PHE C 176 SHEET 3 CE 5 ILE C 204 TYR C 212 -1 N SER C 205 O ASP C 167 SHEET 4 CE 5 LYS C 103 VAL C 116 1 O GLY C 111 N ILE C 207 SHEET 5 CE 5 ILE C 119 GLN C 120 -1 O ILE C 119 N VAL C 116 SHEET 1 CF 5 TYR C 174 ASP C 177 0 SHEET 2 CF 5 LYS C 161 MET C 168 -1 O ILE C 164 N PHE C 176 SHEET 3 CF 5 ILE C 204 TYR C 212 -1 N SER C 205 O ASP C 167 SHEET 4 CF 5 LYS C 103 VAL C 116 1 O GLY C 111 N ILE C 207 SHEET 5 CF 5 GLU C 124 LYS C 130 -1 O GLU C 124 N ALA C 112 SHEET 1 CG 2 ASN C 132 THR C 134 0 SHEET 2 CG 2 THR C 198 LYS C 200 -1 O LEU C 199 N VAL C 133 SHEET 1 DA 8 GLU D 40 TRP D 43 0 SHEET 2 DA 8 ASP D 29 ASP D 35 -1 O HIS D 33 N VAL D 42 SHEET 3 DA 8 SER D 19 PHE D 26 -1 O PHE D 22 N VAL D 34 SHEET 4 DA 8 HIS D 5 ASN D 15 -1 O ILE D 8 N ASP D 25 SHEET 5 DA 8 PHE E 7 PHE E 18 -1 O PHE E 7 N ASN D 15 SHEET 6 DA 8 ARG E 23 TYR E 32 -1 O ARG E 23 N PHE E 18 SHEET 7 DA 8 GLU E 35 ASP E 41 -1 O GLU E 35 N TYR E 32 SHEET 8 DA 8 TYR E 47 ALA E 49 -1 O ARG E 48 N ARG E 39 SHEET 1 DB 4 GLU D 88 THR D 93 0 SHEET 2 DB 4 ASN D 103 PHE D 112 -1 O ILE D 106 N LEU D 92 SHEET 3 DB 4 PHE D 145 PHE D 153 -1 O PHE D 145 N PHE D 112 SHEET 4 DB 4 LEU D 138 PRO D 139 1 O LEU D 138 N ARG D 146 SHEET 1 DC 4 GLU D 88 THR D 93 0 SHEET 2 DC 4 ASN D 103 PHE D 112 -1 O ILE D 106 N LEU D 92 SHEET 3 DC 4 PHE D 145 PHE D 153 -1 O PHE D 145 N PHE D 112 SHEET 4 DC 4 SER D 133 GLU D 134 -1 O SER D 133 N TYR D 150 SHEET 1 DD 2 LEU D 138 PRO D 139 0 SHEET 2 DD 2 PHE D 145 PHE D 153 1 O ARG D 146 N LEU D 138 SHEET 1 DE 4 LYS D 126 VAL D 128 0 SHEET 2 DE 4 ASN D 118 ARG D 123 -1 O TRP D 121 N VAL D 128 SHEET 3 DE 4 VAL D 160 GLU D 166 -1 O ASP D 162 N LEU D 122 SHEET 4 DE 4 LEU D 174 GLU D 179 -1 O LEU D 174 N VAL D 165 SHEET 1 EA 4 LYS E 98 PRO E 103 0 SHEET 2 EA 4 ASN E 113 PHE E 122 -1 O VAL E 116 N TYR E 102 SHEET 3 EA 4 PHE E 155 THR E 163 -1 O PHE E 155 N PHE E 122 SHEET 4 EA 4 ILE E 148 GLN E 149 1 O ILE E 148 N GLN E 156 SHEET 1 EB 4 LYS E 98 PRO E 103 0 SHEET 2 EB 4 ASN E 113 PHE E 122 -1 O VAL E 116 N TYR E 102 SHEET 3 EB 4 PHE E 155 THR E 163 -1 O PHE E 155 N PHE E 122 SHEET 4 EB 4 VAL E 142 SER E 144 -1 O VAL E 143 N MET E 160 SHEET 1 EC 2 ILE E 148 GLN E 149 0 SHEET 2 EC 2 PHE E 155 THR E 163 1 O GLN E 156 N ILE E 148 SHEET 1 ED 4 GLN E 136 GLU E 138 0 SHEET 2 ED 4 GLU E 128 ARG E 133 -1 O TRP E 131 N GLU E 138 SHEET 3 ED 4 TYR E 171 GLU E 176 -1 O THR E 172 N PHE E 132 SHEET 4 ED 4 LEU E 184 TRP E 188 -1 O LEU E 184 N VAL E 175 SSBOND 1 CYS A 23 CYS A 89 1555 1555 2.04 SSBOND 2 CYS A 133 CYS A 183 1555 1555 2.03 SSBOND 3 CYS A 158 CYS B 171 1555 1555 2.05 SSBOND 4 CYS B 25 CYS B 93 1555 1555 2.00 SSBOND 5 CYS B 145 CYS B 210 1555 1555 2.03 SSBOND 6 CYS C 82 CYS C 92 1555 1555 2.06 SSBOND 7 CYS D 107 CYS D 163 1555 1555 2.06 SSBOND 8 CYS E 15 CYS E 79 1555 1555 2.08 SSBOND 9 CYS E 117 CYS E 173 1555 1555 2.01 LINK O HOH A2030 NA NA C1216 1555 1555 2.18 LINK O HIS C 23 NA NA C1216 1555 1555 2.22 LINK O SER C 77 NA NA C1216 1555 1555 2.47 LINK OG SER C 77 NA NA C1216 1555 1555 2.50 LINK NA NA C1216 O HOH C2011 1555 1555 2.47 LINK NA NA C1216 O HOH C2028 1555 1555 2.71 CISPEP 1 SER A 7 PRO A 8 0 -6.37 CISPEP 2 SER B 9 PRO B 10 0 -5.29 CISPEP 3 TYR B 151 PRO B 152 0 0.75 CISPEP 4 ALA B 243 ASP B 244 0 4.26 CISPEP 5 ASN D 15 PRO D 16 0 0.22 CISPEP 6 THR D 113 PRO D 114 0 0.06 CISPEP 7 PRO E 108 LEU E 109 0 0.84 CISPEP 8 TYR E 123 PRO E 124 0 4.01 SITE 1 AC1 5 HOH A2030 HIS C 23 SER C 77 HOH C2011 SITE 2 AC1 5 HOH C2028 SITE 1 AC2 7 GLU A 17 ARG A 163 SER A 164 HOH A2092 SITE 2 AC2 7 SER B 168 ARG B 195 GOL B1245 SITE 1 AC3 5 GLU A 17 GOL A1201 HOH A2092 VAL B 196 SITE 2 AC3 5 SER B 197 SITE 1 AC4 5 ARG B 110 ASP B 153 GLN B 175 PRO B 176 SITE 2 AC4 5 TYR B 188 SITE 1 AC5 5 ASN B 30 HIS B 31 ASP B 32 SER B 97 SITE 2 AC5 5 ARG B 98 CRYST1 191.180 48.890 166.720 90.00 113.55 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005231 0.000000 0.002280 0.00000 SCALE2 0.000000 0.020454 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006543 0.00000